Smashed Peaches

Drug Research Studies

FibroGen, Inc. (FGEN) Analysts See $-0.65 EPS; Select Medical Holdings (SEM) Covered By 1 Bulls – The FinExaminer

Analysts expect FibroGen, Inc. (NASDAQ:FGEN) to report $-0.65 EPS on May, 8.They anticipate $0.15 EPS change or 30.00% from last quarter’s $-0.5 EPS. After having $0.23 EPS previously, FibroGen, Inc.’s analysts see -382.61% EPS growth. The stock decreased 0.35% or $0.19 during the last trading session, reaching $54.06. About 64,792 shares traded. FibroGen, Inc. (NASDAQ:FGEN) has risen 6.81% since April 11, 2018 and is uptrending. It has outperformed by 2.44% the S&P500. Some Historical FGEN News: 28/03/2018 – Andes Technology Corp. to Present & Exhibit at Design & Reuse IP SOC Conference; 13/03/2018 Announcing The First Andes Summit – Indigenous Wisdom-Keepers to Gather With People of The North to lnitiate a New Commitment to Earth Healing; 12/04/2018 – $GLPG moving fast into #IPF Ph3 vs. $FGEN still at a snail’s pace; 31/05/2018 – ASTELLAS PHARMA INC – SAFETY PROFILE OF ROXADUSTAT WAS CONSISTENT WITH THAT OBSERVED IN PREVIOUS STUDIES BOTH IN DIALYSIS AND NON-DIALYSIS PATIENTS; 23/04/2018 – DJ FibroGen Inc, Inst Holders, 1Q 2018 (FGEN); 21/05/2018 – FIBROGEN: PAMREVLUMAB SLOWED IPF DISEASE PROGRESSION IN STUDY; 07/05/2018 – RESOURCE CAPITAL FUND Vl L.P. ANNOUNCES ACQUISITION OF UNITS IN LOS ANDES COPPER LTD; 31/05/2018 – ASTELLAS PHARMA INC – ROXADUSTAT WAS WELL TOLERATED IN STUDY; 21/05/2018 – FibroGen Presents Latest Data From PRAISE Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at American Thoracic Society 2018; 18/04/2018 – The Andes Summit: More Than Ayahuasca – A Re-Validation of the Cultural Heritage of Ecuador’s Ancient Indigenous Wisdom

Among 3 analysts covering Select Medical Holdings (NYSE:SEM), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Select Medical Holdings had 5 analyst reports since October 16, 2018 according to SRatingsIntel. The stock of Select Medical Holdings Corporation (NYSE:SEM) earned “Neutral” rating by Credit Suisse on Monday, January 7. Credit Suisse maintained it with “Neutral” rating and $21 target in Monday, November 5 report. RBC Capital Markets maintained the shares of SEM in report on Monday, February 25 with “Buy” rating. See Select Medical Holdings Corporation (NYSE:SEM) latest ratings:

25/02/2019 Broker: RBC Capital Markets Rating: Buy New Target: $23 Maintain
07/01/2019 Broker: Credit Suisse Old Rating: Neutral New Rating: Neutral Old Target: $21 New Target: $16 Maintain
14/12/2018 Broker: Barclays Capital Rating: Equal-Weight New Target: $20 Initiates Coverage On
05/11/2018 Broker: Credit Suisse Old Rating: Neutral New Rating: Neutral Old Target: $18 New Target: $21 Maintain
16/10/2018 Broker: Credit Suisse Rating: Neutral New Target: $18 Initiates Coverage On

The stock increased 0.27% or $0.04 during the last trading session, reaching $14.63. About 18,970 shares traded. Select Medical Holdings Corporation (NYSE:SEM) has declined 17.54% since April 11, 2018 and is downtrending. It has underperformed by 21.91% the S&P500. Some Historical SEM News: 07/05/2018 – Select Medical at Deutsche Bank Health Care Conference Tomorrow; 03/05/2018 – SELECT MEDICAL 1Q OPER REV. $1.25B, EST. $1.23B; 23/04/2018 – DJ Select Medical Holdings Corporation, Inst Holders, 1Q 2018 (SEM); 03/05/2018 – Select Medical Sees FY Rev $5B-$5.2B; 29/03/2018 Select Medical Closes Below 200-Day Moving Average: Technicals; 02/04/2018 – Fidelity Select Medical Equipment Adds Edwards Life; 03/05/2018 – SELECT MEDICAL 1Q ADJ EPS 29C, EST. 26C; 03/05/2018 – SELECT MEDICAL HOLDINGS CORP SEM.N SEES FY 2018 ADJUSTED SHR $0.97 TO $1.12; 03/05/2018 – SEM REAFFIRMS 2018 OUTLOOK FOR OPER REV., ADJUSTED EBITDA; 30/04/2018 – Fidelity Select Medical Equipment Adds Teleflex, Exits CVS

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company has market cap of $1.98 billion. The companyÂ’s Specialty Hospitals segment operates long term acute care hospitals and inpatient acute rehabilitative hospitals. It has a 14.34 P/E ratio. This segment offers various medical services for the treatment of respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders, and cancer.

More notable recent Select Medical Holdings Corporation (NYSE:SEM) news were published by: Fool.com which released: “The 3 Stocks on the MFM Team’s Radar This Week – The Motley Fool” on March 28, 2019, also Gurufocus.com with their article: “Largest Insider Trades of the Week – GuruFocus.com” published on March 22, 2019, Seekingalpha.com published: “Select Medical misses by $0.02, misses on revenue – Seeking Alpha” on February 21, 2019. More interesting news about Select Medical Holdings Corporation (NYSE:SEM) were released by: Seekingalpha.com and their article: “Select Medical sees almost $1.3B in Q3 revenue – Seeking Alpha” published on October 10, 2018 as well as Seekingalpha.com‘s news article titled: “Select Medical Holdings Corporation (SEM) Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: November 02, 2018.

Investors sentiment increased to 1.48 in Q4 2018. Its up 0.57, from 0.91 in 2018Q3. It increased, as 20 investors sold Select Medical Holdings Corporation shares while 46 reduced holdings. 33 funds opened positions while 65 raised stakes. 102.60 million shares or 1.62% more from 100.97 million shares in 2018Q3 were reported. Moreover, D E Shaw & has 0.01% invested in Select Medical Holdings Corporation (NYSE:SEM). Envestnet Asset Management owns 27,796 shares or 0% of their US portfolio. Jefferies Grp Ltd Liability Corp owns 14,913 shares. Mason Street Advsr Limited Liability Com stated it has 33,622 shares. Jennison Associates Limited Liability holds 0% of its portfolio in Select Medical Holdings Corporation (NYSE:SEM) for 83,316 shares. Bessemer Gp holds 0.01% or 115,391 shares. Riverhead Capital Mgmt Ltd Liability Co has 14,155 shares. Dimensional Fund L P holds 0.05% or 7.39M shares. Petrus Tru Com Lta has invested 0.07% of its portfolio in Select Medical Holdings Corporation (NYSE:SEM). Foundry Ptnrs has 502,147 shares for 0.35% of their portfolio. Broadview Advsrs Ltd Llc reported 1.04% stake. Moreover, Voya Investment Mngmt Limited Liability Corporation has 0.07% invested in Select Medical Holdings Corporation (NYSE:SEM) for 1.97 million shares. Martingale Asset L P invested in 0.03% or 164,885 shares. 36,730 were reported by Metropolitan Life Insur Ny. Assetmark has 24 shares for 0% of their portfolio.

More notable recent FibroGen, Inc. (NASDAQ:FGEN) news were published by: Nasdaq.com which released: “Options Traders Expect Huge Moves in FibroGen (FGEN) Stock – Nasdaq” on April 03, 2019, also Nasdaq.com with their article: “Akebia Expands Vadadustat Licensing Deal With Vifor Pharma – Nasdaq” published on April 10, 2019, Nasdaq.com published: “U.S. STOCKS ON THE MOVE-Avaya, Curis, The9, Recro Pharma – Nasdaq” on March 25, 2019. More interesting news about FibroGen, Inc. (NASDAQ:FGEN) were released by: Nasdaq.com and their article: “Add Up The Pieces: IYH Could Be Worth $217 – Nasdaq” published on March 14, 2019 as well as Benzinga.com‘s news article titled: “Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs (March: 24-30) – Benzinga” with publication date: March 23, 2019.


Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.